WP6 Mechanistic Studies

WP objectives:

  • To detail the effects of incretin-based therapies, both GLP-1 receptor agonists and DPP-4 inhibitors, on the cardiovascular system and the kidney in humans.
  • To study the mechanisms underlying the effects of incretin-based therapies on the cardiovascular system and the kidney in humans.
  • To study the effects on the digestive system in humans.